Story perspectives

New Tests Could Predict 84% of Myeloma Relapses

10/13/2025

50 8

Summary

Story summary

A study from the Institute of Cancer Research (ICR) shows that combining DNA tests with RNA gene expression tests can predict early relapses in multiple myeloma, affecting about 33,000 people in the UK.
Researchers tracked 135 patients and found that 18.5% relapsed within 18 months post-treatment.
By integrating both testing methods, researchers estimate they could predict 84% of early relapses, potentially transforming patient care.
The Royal Marsden Hospital plans to offer gene expression profiling tests starting in 2026.

1 of 1

Story summary

A study from the Institute of Cancer Research (ICR) shows that combining DNA tests with RNA gene expression tests can predict early relapses in multiple myeloma, affecting about 33,000 people in the UK.
Researchers tracked 135 patients and found that 18.5% relapsed within 18 months post-treatment.
By integrating both testing methods, researchers estimate they could predict 84% of early relapses, potentially transforming patient care.
The Royal Marsden Hospital plans to offer gene expression profiling tests starting in 2026.